Artios Pharma Investor
Artios Pharma is a independent DNA Damage Response company with a strong pipeline of novel cancer therapies.
Technology:
AgeTech Companies
Industry:
Healthcare
Headquarters:
Cambridge, Cambridgeshire, United Kingdom
Founded Date:
2016-01-01
Employees Number:
101-250
Funding Status:
Late Stage Venture
Estimated Revenue:
$10M to $50M
Register and Claim Ownership